The Significance of Perfusion Defect at Myocardial Perfusion MR Imaging in a Cat Model of Acute Reperfused Myocardial Infarction

Korean Journal of Radiology

Volumn 3, Issue 4, 2002, Pages 235-239

  Goo, Hyun Woo ^a   Kim, Dong Hun ^a   Lee, Seoung Soo ^a   Park, Sung Bin ^a   Lim, Tae Hwan ^a,b  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

Coronary vessels, stenosis or obstruction; Heart, experimental studies; Magnetic resonance (MR), comparative studies; Magnetic resonance (MR), contrast agents; Myocardium, infarction; Myocardium, MR

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM; GADOLINIUM PENTETATE; GADOPHRIN 2; GADOPHRIN-2; MESOPORPHYRIN; METALLOPORPHYRIN;

ANIMAL; ARTICLE; CAT; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE REPERFUSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

ANIMALS; CATS; CONTRAST MEDIA; GADOLINIUM; GADOLINIUM DTPA; MAGNETIC RESONANCE IMAGING; MESOPORPHYRINS; METALLOPORPHYRINS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM;

EID: 0037507447     PISSN: 12296929     EISSN: None     Source Type: Journal    
DOI: 10.3348/kjr.2002.3.4.235     Document Type: Article

References (19)

1. Lim TH, Hong MK, Lee JS, et al. Novel application of breath-hold turbo spin-echo T2 MRI for detection of acute myocardial infarction. J Magn Reson Imaging 1997;7:996-1001
2. Higgins CB, Herfkens R, Lipton MJ, et al. Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol 1983;52:184-188
3. Choi SI, Jiang CZ, Lim KH, et al. Application of breath-hold T2-weighted, first-pass perfusion and gadolinium-enhanced T1-weighted MR imaging for assessment of myocardial viability in a pig model. J Magn Reson Imaging 2000;11:476-480
4. Pislaru SV, Ni Y, Pislaru C, et al. Noninvasive measurements of infarct size after thrombolysis with a necrosis-avid MRI contrast agent. Circulation 1999;99:690-696
5. Wilke N, Simm C, Zhang J, et al. Contrast-enhanced first pass myocardial perfusion imaging. Magn Reson Med 1993;29:485-497
6. Judd RM, Lugo-Olivieri CH, Arai M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995;92:1902-1910
7. Saeed M, Wendland MF, Matusi T, Higgins CB. Reperfused myocardial infarctions on T1-and susceptibility-enhanced MRI: evidence for loss of compartmentalization of contrast media. Magn Reson Med 1994;31:31-39
8. Lim TH, Lee JG, Lee TK, Mun CW. Comparison of gadolinium polylysine and gadopentetate in contrast-enhanced MR imaging of myocardial ischemia-reperfusion in cats. J Korean Radiol Soc 1995;33:59-65
9. Choi SI, Choi SH, Kim ST, et al. Irreversibly damaged myocardium at MR imaging with a necrotic tissue-specific contrast agent in a cat model. Radiology 2000;215:863-868
10. Saeed M, Bremerich J, Wendland MF, Wyttenbach R, Weinmann HJ, Higgins CB. Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats. Radiology 1999;213:247-257
11. Rogers WJ, Kramer CM, Geskin G, et al. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. Circulation 1999;99:744-750
12. Stillman AE, Wilke N, Jerosch-Herold M. Myocardial viability. Radiol Clin North Am 1999;37:361-378
13. Lim T-H, Choi SI. MRI of myocardial infarction. J Magn Reson Imaging 1999;10:686-693
14. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 1989;80:1846-1861
15. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the 'no-reflow' phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-228
16. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-772
17. Kroft LJM, de Roos A. Blood pool contrast agents for cardiovascular MR imaging. J Magn Reson Imaging 1999;10:395-403
18. Ni Y, Marchai G, Yu J, et al. Localization of metalloporphyrininduced "specific" enhancement in experimental liver tumors: comparison of magnetic resonance imaging, microangiographic, and histologic findings. Acad Radiol 1995;2:687-699
19. Marchai G, Ni Y, Herijgers P, et al. Paramagnetic metalloporphyrins: infarct-avid contrast agents for diagnosis of acute myocardial infarction by MRI. Eur Radiol 1996;6:2-8